X-57592199-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_007157.4(ZXDB):c.151C>G(p.Gln51Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,064,395 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007157.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000715 AC: 8AN: 111877Hom.: 0 Cov.: 23 AF XY: 0.0000879 AC XY: 3AN XY: 34115
GnomAD3 exomes AF: 0.0000488 AC: 1AN: 20508Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 2960
GnomAD4 exome AF: 0.000132 AC: 126AN: 952518Hom.: 0 Cov.: 31 AF XY: 0.000103 AC XY: 31AN XY: 302244
GnomAD4 genome AF: 0.0000715 AC: 8AN: 111877Hom.: 0 Cov.: 23 AF XY: 0.0000879 AC XY: 3AN XY: 34115
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.151C>G (p.Q51E) alteration is located in exon 1 (coding exon 1) of the ZXDB gene. This alteration results from a C to G substitution at nucleotide position 151, causing the glutamine (Q) at amino acid position 51 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at